Cytokine Genotype Polymorphisms in Breast Carcinoma: Associations of TGF-β1 with Relapse

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Investigation

• Publication date

  2005-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1081/CNV-200055954PMID 15945506
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Determining Sample Sizes Needed to Detect a Difference between Two Proportions

  2004cited by this paper
• Racial and ethnic composition of volunteer cord blood donors: comparison with volunteer unrelated marrow donors

  2002cited by this paper
• Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects

  2002cited by this paper
• Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study.

  2002cited by this paper
• Association between the T29-->C polymorphism in the transforming growth factor beta1 gene and breast cancer among elderly white women: The Study of Osteoporotic Fractures.

  2001cited by this paper
• Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells

  2001cited by this paper
• Extracellular Signaling through the Microenvironment: A Hypothesis Relating Carcinogenesis, Bystander Effects, and Genomic Instability

  2001cited by this paper
• Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation.

  2001cited by this paper
• Interferon- g and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation

  2001cited by this paper
• Polymorphism of the transforming growth factor-beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation.

  2000cited by this paper
• Interleukin 6, tumour necrosis factor alpha, interleukin 1beta and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma.

  2000cited by this paper
• Interleukin 6, tumour necrosis factor α, interleukin 1β and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma

  2000cited by this paper
• Direct influences of pro-inflammatory cytokines (IL-1beta, TNF-alpha, IL-6) on the proliferation and cell-surface antigen expression of cancer cells.

  2000cited by this paper
• In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene.

  1999cited by this paper
• Regulators of apoptosis in human breast cancer.

  1999cited by this paper
• Correlation between p53, c‐erbB‐2, and topoisomerase IIα expression, DNA ploidy, hormonal receptor status and proliferation in 356 node‐negative breast carcinomas: prognostic implications

  1999cited by this paper
• Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.

  1999cited by this paper
• Cytokine gene polymorphisms predict acute graft rejection following renal transplantation.

  1999cited by this paper
• Pathology and behavior of small breast carcinomas.

  1999cited by this paper
• Molecular staging of prostate cancer: dream or reality?

  1999cited by this paper
• Genetic control of the circulating concentration of transforming growth factor type beta1.

  1999cited by this paper
• Direct influences of proinflammatory cytokines (IL-1β, TNF-α, IL-6) on the proliferation and the cell-surface antigen expression of cancer cells

  1998cited by this paper
• Influence of cytokine genotypes on allograft rejection.

  1998cited by this paper
• Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants.

  1998cited by this paper
• Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency

  1998cited by this paper
• Polymorphism in the tumor necrosis factor‐α promotor region and in the heat shock protein 70 genes associated with malignant tumors

  1997cited by this paper
• Implications for immunosurveillance of altered HLA class I phenotypes in human tumours.

  1997cited by this paper
• Transforming growth factor-beta in breast cancer: a working hypothesis.

  1997cited by this paper
• Transforming growth factor-β in breast cancer: A working hypothesis

  1997cited by this paper
• Cytokine gene polymorphism and heart transplant rejection.

  1997cited by this paper
• Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.

  1997cited by this paper
• Adjuvant chemotherapy in the node-negative breast cancer patient.

  1996cited by this paper
• [Transforming growth factor-beta and its receptors].

  1996cited by this paper
• Non-classical-MHC genetics of immunological disease in man and mouse. The key role of pro-inflammatory cytokine genes.

  1996cited by this paper
• Lack of transforming growth factor-beta 1 expression in benign skin tumors of p53null mice is prognostic for a high risk of malignant conversion.

  1994cited by this paper

• IL-6 Promoter Polymorphisms and Breast Cancer Susceptibility: A Meta-Analysis of 16,499 Cases and 21,186 Controls

  2026cites this paper
• Prevention and Co-Management of Breast Cancer-Related Osteoporosis Using Resveratrol

  2024cites this paper
• Analysis of Interleukin-6 Gene Variants (rs1800795, rs1800796, rs1554606, rs1800797, rs2069840, rs12700386, and rs2069861) as Prognostic Markers in Breast Cancer: A Systematic Review, Meta-Analysis, and Network Analysis

  2023cites this paper
• Associations of interleukin-6 gene polymorphisms with cancer risk: Evidence based on 49,408 cancer cases and 61,790 controls.

  2018cites this paper
• The prognostic value of IL10 and TNF alpha functional polymorphisms in premenopausal early-stage breast cancer patients

  2015cites this paper
• Circulating interleukin-6 and cancer: A meta-analysis using Mendelian randomization

  2015cites this paper
• Genetic polymorphisms of IL-6 promoter in cancer susceptibility and prognosis: a meta-analysis

  2015cites this paper
• Tumour Necrosis Factor-α Gene Polymorphism Is Associated with Metastasis in Patients with Triple Negative Breast Cancer

  2015cites this paper
• TGF‐β1 and IL‐10 single nucleotide polymorphisms as risk factors for oral cancer in Taiwanese

  2015cites this paper
• RETRACTED ARTICLE: Correlations of IFN-γ genetic polymorphisms with susceptibility to breast cancer: a meta-analysis

  2014cites this paper
• AB123. IL-6 2174G>C polymorphism and cancer risk: a meta-analysis involving 29,377 cases and 37,739 controls

  2014cites this paper
• Transforming growth factor beta1 (TGFβ1) polymorphisms and breast cancer risk

  2014cites this paper
• Retraction Note to: Correlations of IFN-γ genetic polymorphisms with susceptibility to breast cancer: a meta-analysis

  2014cites this paper
• Role of cytokine gene (interferon‐γ, transforming growth factor‐β1, tumor necrosis factor‐α, interleukin‐6, and interleukin‐10) polymorphisms in the risk of oral precancerous lesions in Taiwanese

  2014cites this paper
• Lack of association between interferon gamma +874 T/A polymorphism and cancer risk: an updated meta-analysis

  2014cites this paper
• IFN-γ+874 A/T polymorphism and cancer risk: an updated analysis based on 32 case-control studies.

  2011cites this paper
• TNF-alpha polymorphisms and breast cancer

  2011cites this paper
• Data in a recent meta-analysis about TNF-alpha polymorphisms and breast cancer susceptibility need for clarification

  2011cites this paper
• IL-6 −174G>C polymorphism and cancer risk: a meta-analysis involving 29,377 cases and 37,739 controls

  2011cites this paper
• TNFα −308 G/A polymorphism is associated with breast cancer risk: a meta-analysis involving 10,184 cases and 12,911 controls

  2010cites this paper
• PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).

  2010cites this paper
• Transforming growth factor-β1 polymorphisms and breast cancer risk: a meta-analysis based on 27 case–control studies

  2010cites this paper
• Lack of an association between a functional polymorphism in the interleukin-6 gene promoter and breast cancer risk: a meta-analysis involving 25,703 subjects

  2010cites this paper
• PTGS 2 and IL 6 genetic variation and risk of breast and prostate cancer : results from the Breast and Prostate Cancer Cohort Consortium ( BPC 3 )

  2010cites this paper
• Evaluation of single nucleotide polymorphisms (SNPs) in the p53 binding protein 1 (TP53BP1) gene in breast cancer patients treated with breast-conserving surgery and whole-breast irradiation (BCS + RT).

  2009cites this paper
• Genetic polymorphisms in the transforming growth factor-beta signaling pathways and breast cancer risk and survival.

  2009cites this paper
• Molecular screening of interleukin-6 gene promoter and influence of -174G/C polymorphism on breast cancer.

  2009cites this paper
• Apoptosis‐Inducing High .NO Concentrations Are Not Sustained Either in Nascent or in Developed Cancers

  2008cites this paper
• TGF-β1 genotype and phenotype in breast cancer and their associations with IGFs and patient survival

  2008influential citation
• The involvement of IL‐10, IL‐6, IFN‐γ, TNF‐α and TGF‐β gene polymorphisms among Turkish lung cancer patients

  2008cites this paper
• Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review

  2006cites this paper
• Cytokines in breast cancer.

  2006influential citation
• Association of cytokine gene polymorphisms with malignant melanoma in Caucasian population

  2006cites this paper
• Interrelationships and clinical significance of expression of immunological markers in invasive breast carcinoma

  2006influential citation